Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENIPNEUMO study of oral penicillin V versus amoxicillin for non-severe community-treated pneumonia
2012-003511-63Phase 4Completed
- Sponsor
- IDIAPJGol
- Start
- Sep 2012
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of phenoxymethylpenicillin and amoxicillin in community-acquired pneumonia (CAP) and pneumonia (2 arms), sponsored by IDIAPJGol. Primary endpoint: Clinical resolution at 14 days. Started Sep 2012; status: completed.
02
Drugs
phenoxymethylpenicillinamoxicillin
03
Conditions
community-acquired pneumonia (CAP)pneumonia
Beyond the preview
Go deeper on 2012-003511-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003511-63.